| |
Cystic Fibrosis Worldwide is in official relation with the World Health
Organization. Together with the CFW(ICFMA/IACFA),
WHO has produced the following documentation and guidelines in the
care and treatment of persons with cf.
WHO guidelines for the diagnosis and management of
cf 
This publication is intended primarily
for pediatrician, physicians and other health professionals involved
in the diagnosis and care of patients with cystic fibrosis. Few
diseases illustrate more vividly the inequalities in knowledge,
practice and resources which exist between the health services of
affluent, 'developed' countries and those at an earlier stage of
'development'.
This Manual is designed to
help Cystic Fibrosis patients and their parents to have a better
understanding of Cystic Fibrosis as a disease. It has been produced
jointly by the World Health Organization (WHO) and the International
Cystic Fibrosis (Mucoviscidosis) Association (ICF(M)A), in response
to requests for a simple document which is suitable for families
in all countries who may have difficulty in attending a well-developed
specialist CF clinic or obtaining detailed information about the
disease.

* Available in English, Arabic, Turkish and Spanish.
Special thanks to the translators:
Heba Mohammad Shawky & Sabry Gameel Hameed
Burak Baytu - Contact: bbaytu@baytu.com - www.baytu-linguistics.com
Implementation
of CF Services in developing countries 
Although CF is a serious genetic
disease which is widespread throughout the world, there are significant
variations in incidence with relative sparing of the African and
Oriental races. Although recognition of CF and provision of appropriate
clinical services are well developed in Western Europe, the USA
and Australia, there are large populations in whom the disease is
infrequently recognized and inadequately treated, with consequent
avoidable death and suffering in infancy, childhood and adult life.
Services
for adults with Cystic Fibrosis 
Cystic fibrosis is a genetic disease
with significant variations in incidence, morbidity and mortality
around the world. Although most often reported in white Caucasians,
since discovery of the mutated gene in 1989 [4] it is also being
diagnosed with increasing frequency in other populations, often
with variant clinical expression.
WHO report
classification of cf and related disorders

Making a diagnosis of Cystic Fibrosis
(CF) is not always simple.1 Initially, CF was recognized as a clinical
syndrome. Many diagnostic problems were resolved by the development
of the sweat test in 1950.2 The test remains clinically reliable
for most cases,3 but the occasional occurrence of false-negative
and false-positive results has always been recognized.
You
will need Acrobat Reader
to view the above documents. |

The
molecular genetic epidemiology of cystic fibrosis
Report of a joint meeting of
WHO/ECFTN/
ICF(M)A/ECFS
Download PDF
|